The EU-funded project “Interregional coordination for a fast and deep uptake of Personalised Medicine” – Regions4PerMed has entered its last phase and Key Thematic Area – Tackling ethical, economical, legal, and social aspects of Personalised Medicine, whose implementation consists of the organization of a Conference and a Workshop that will be carried within 2022.
In 2014, the Horizon 2020 Advisory Group has defined PM as a medical model using characterization of individuals’ phenotypes and genotypes (e.g., molecular profiling, medical imaging and lifestyle data) to tailor the right therapeutic strategy to the right person at the right time, determine the predisposition to disease and deliver timely and targeted prevention. The definition has been adopted by the European Council Conclusion on PM for patients, which specified that “Personalised medicine relates to the broader concept of patient-centered care, which takes into account that, in general, healthcare systems need to better respond to patient needs” (2015/C 421/03).
While more and more countries are introducing whole genome sequencing and Personalised Medicine approaches into clinical care, the awareness about the ethical, economic, legal and social implication of Personalised Medicine are becoming central in the public discourse.
In this perspective, Regions4PerMed is organizing a Conference on “Tackling ethical, economical, legal, and social aspects of Personalised Medicine”, with a special focus on:
- Ethical aspects
- Public trust
- The economic value of Personalised Medicine
- Diversity, inclusion and Personalised Medicine
- Sex, gender and Personalised Medicine
International speakers will be present to provide their precious insights on these socio-economic aspects of Personalised Medicine.
Have a look at the full agenda and register to the event, either online or in person, here!
The Coordination and Support Action Regions4PerMed is part of the ICPerMed family.
